A4/LEARN Data Use Agreement
One-time, non-transferable license for the purposes stated in an approved data use application (scientific investigation, teaching or planning clinical research). The data must not be commercialized or redistributed, AI tools must keep inputs and model weights confidential, publications must credit A4/LEARN, and the data must be destroyed after five years.
Our reading of the license, not legal advice. Before you use the data, read the original license and confirm that your use is allowed. We take no responsibility for how you use a dataset. Full disclaimer
What you can do
- No
- Conditional
- Not stated
- Conditional
What you can share
- No
- Not stated
- Not stated
What you must do
- Yes
- Share alike No
- Yes
- Not stated
- Manuscript review No
- Release code No
- No
- Yes
Limits
- Yes
- Conditional
Separate commercial license: Not stated No commercial license offer is published; the agreement states the data package shall not be commercialized.
Datasets under this license
- A4 and LEARN
Shared data package of the A4 solanezumab prevention trial and its amyloid-negative companion study LEARN: 7,133 longitudinal 3T MRI sessions with T2*-GRE, plus amyloid and tau PET, from cognitively unimpaired adults aged 65 to 85, with central MRI safety reads for microhemorrhages.